$BIIB Company News

New Post Public Reply Private Reply Replies (1) Message Board

Apr 22, 2014 at 11:18 AM

$BIIB Company News

Apple, Microsoft are not the keys to this week’s news
7:00 a.m. Today7:00 a.m. April 22, 2014
- Marek Fuchs

Long view on stocks is best during weak earnings season
6:00 a.m. April 20, 2014
- Wallace Witkowski

Biotech misses out on Nasdaq rally, sinks further into bear ground

4:58 p.m. April 14, 2014
- blogs.marketwatch.com

Herbalife sinks on probe fears; Zoe’s surges on debut
4:36 p.m. April 11, 2014
- Ben Eisen

Stocks fall for 3rd day in row; S&P 500 down for year again: stock market live blog recap

4:11 p.m. April 7, 2014
- blogs.marketwatch.com

Biotech bargain?
11:43 a.m. April 1, 2014
- The Trading Deck

Facebook, Biogen, Cal-Maine are stocks to watch
5:21 a.m. March 31, 2014
- Victor Reklaitis

U.S. stocks end week with losses
7:17 p.m. March 28, 2014
- Anora Mahmudova

Nasdaq pullback rife with opportunity
2:07 p.m. March 25, 2014
- The Trading Deck

Biotech comeback stalls as Wall Street starts to worry

12:45 p.m. March 25, 2014
- blogs.marketwatch.com

U.S. stocks fall; Nasdaq skids 1.2%
4:40 p.m. March 24, 2014
- Anora Mahmudova

Biotech has second straight sell-off; sector mutual funds take it on chin

10:40 a.m. March 24, 2014
- blogs.marketwatch.com

First Solar extends winning streak; Symantec plunges
3:06 p.m. March 21, 2014
- Ben Eisen

Investors let air out of biotech amid overheating, pricing concerns

1:42 p.m. March 21, 2014
- blogs.marketwatch.com

U.S. stocks rise; S&P 500 positive for the year
4:39 p.m. March 17, 2014
- Anora Mahmudova

Yahoo gains on Alibaba IPO; Plug Power loses momentum
4:17 p.m. March 17, 2014
- Saumya Vaishampayan

Keurig Green Mountain added to S&P 500 index
9:56 a.m. March 15, 2014
- MarketWatch.com

From every angle, technicals point to richer stocks
2:25 p.m. March 11, 2014
- The Trading Deck

Stocks close mostly higher after jobs report beats forecasts: stock market live blog recap

4:03 p.m. March 7, 2014
- blogs.marketwatch.com

Best stocks for legalized marijuana

1:37 p.m. Feb. 27, 2014
- blogs.marketwatch.com

Insider Trading Alert - BIIB, JAZZ And KWK Traded By Insiders

10:15 a.m. Today10:15 a.m. April 22, 2014
- TheStreet.com

Cytokinetics, Incorporated (CYTK) Jumps: Stock Up 13.5% - Tale of the Tape

9:39 a.m. Today9:39 a.m. April 22, 2014
- Zacks.com

Zacks Rank #1 Additions for Tuesday - Tale of the Tape

9:30 a.m. Today9:30 a.m. April 22, 2014
- Zacks.com

Sarepta Therapeutics (SRPT) Soars: Stock Up 39.3% - Tale of the Tape

8:51 a.m. Today8:51 a.m. April 22, 2014
- Zacks.com

ANI Pharmaceuticals, Inc. (ANIP) Looks Strong: Stock Soars 20.7% - Tale of the Tape

8:44 a.m. Today8:44 a.m. April 22, 2014
- Zacks.com

Should You Get Rid of Retrophin (RTRX) Now? - Tale of the Tape

8:41 a.m. Today8:41 a.m. April 22, 2014
- Zacks.com

Will Amgen (AMGN) Miss This Earnings Season? - Analyst Blog

6:20 p.m. April 21, 2014
- Zacks.com

Biotech Is Not A Popping Bubble: Buy The Dip While You Can

2:34 p.m. April 21, 2014
- Seeking Alpha

Will Gilead (GILD) Beat Q1 Earnings? - Analyst Blog

10:50 a.m. April 21, 2014
- Zacks.com

Gilead heads Citi's 20 best stocks in America

10:28 a.m. April 21, 2014
- Seeking Alpha

3 Stocks Reiterated As A Buy: MU, VZ, BIIB

9:59 a.m. April 21, 2014
- TheStreet.com

Today's Market: Other Potential Buyout Targets For Pfizer

8:54 a.m. April 21, 2014
- Seeking Alpha

Biogen Idec Signs License Agreement With Amunix for XTENylated Factor VIII; Amunix Could Recieve up to $39M

7:02 a.m. April 21, 2014
- benzinga.com

Biohazard? Gilead Leads 5 Big-Cap Biotech Earnings

11:12 a.m. April 18, 2014
- Investors Business Daily

Xenoport's Path Is Long, But The Potential Is There

8:31 p.m. April 17, 2014
- Seeking Alpha

AbbVie Candidate in Pivotal Study - Analyst Blog

12:32 p.m. April 17, 2014
- Zacks.com

Biotech Stock Mailbag: NeoStem, Gilead and the Importance of Big-Cap Biotech Earnings

9:18 a.m. April 17, 2014
- TheStreet.com

Biotech Stock Roundup: MannKind PDUFA Date Pushed Out, Alkermes Impresses with Data - Analyst Blog

10:07 a.m. April 16, 2014
- Zacks.com

'Fast Money' Recap: Impressed by Yahoo!

5:00 a.m. April 16, 2014
- TheStreet.com

Will Abbott Labs (ABT) Disappoint This Quarter? - Analyst Blog

11:30 a.m. April 15, 2014
- Zacks.com

Biogen Idec Signs License Agreement With Amunix for XTENylated Factor
VIII
8:02 a.m. April 21, 2014
- Marketwire

RBCC Bioprinting Partner Expands Brand Awareness Campaign
4:28 a.m. April 16, 2014
- BusinessWire - BZX

Surveyed European Neurologists Expect to Prescribe Biogen Idec's Tecfidera to 16 Percent of their Diagnosed Relapsing-Remitting Multiple Sclerosis Patients in the Next 12 Months
1:00 p.m. April 15, 2014
- PR Newswire - PRF

Legal Updates, Stock Price Movements, New Awareness Campaigns, and Senior-level Appointments - Analyst Notes on Mylan, WellPoint, Forest, Novatis and Intercept
8:00 a.m. April 15, 2014
- PR Newswire - PRF

Biogen Idec to Present New Clinical Data from Its Robust Neurology
Portfolio at AAN Annual Meeting
7:30 a.m. April 14, 2014
- BusinessWire - BZX

JPMorgan Chase First Quarter Earnings Falls 20 Percent; FBI Probes Herbalife Business
12:36 a.m. April 14, 2014
- ACCESSWIRE

Pfizer’s Ian Read Becomes PhRMA Board Chairman; Ken Frazier, George
Scangos Assume New Posts
9:00 a.m. April 11, 2014
- BusinessWire - BZX

Biogen Idec Names Adam M. Koppel as SVP and Chief Strategy Officer
7:30 a.m. April 10, 2014
- BusinessWire - BZX

Biogen Idec and Sobi announce positive top-line efficacy and safety results from phase-3 paediatric study of investigational therapy Eloctate(TM) (rFVIIIFc) for haemophilia A
7:06 a.m. April 10, 2014
- Thomson Reuters ONE

Biogen Idec and Sobi Announce Positive Top-Line Efficacy and Safety
Results from Phase 3 Pediatric Study of Investigational Therapy Eloctate™
(rFVIIIFc) for Hemophilia A
7:00 a.m. April 10, 2014
- BusinessWire - BZX

RBCC and n3D Seek Out Additional Capital
5:00 a.m. April 9, 2014
- BusinessWire - BZX

Earnings Release Schedules, Product Portfolio Expansion, Initiatives and Stock Price Movements - Analyst Notes on Biogen Idec, Bristol-Myers, Regeneron Pharma, Illumina, West Pharma Services
8:00 a.m. April 8, 2014
- PR Newswire - PRF

Bioprinting Investment Puts RBCC at Forefront of 3-D Revolution
5:00 a.m. April 3, 2014
- BusinessWire - BZX

Biogen Idec to Report First Quarter 2014 Financial Results on April
23, 2014
4:01 p.m. March 31, 2014
- BusinessWire - BZX

Sobi: US FDA approves Alprolix(TM)
2:05 a.m. March 31, 2014
- GlobeNewswire

Sobi: US FDA approves Alprolix(TM)
2:01 a.m. March 31, 2014
- Thomson Reuters ONE

FDA Approves Biogen Idec’s ALPROLIX™, the First Hemophilia B Therapy
to Reduce Bleeding Episodes with Prophylactic Infusions Starting at
Least a Week Apart
6:34 p.m. March 28, 2014
- BusinessWire - BZX

FDA Approves Biogen Idec’s ALPROLIX™, the First Hemophilia B Therapy
to Reduce Bleeding Episodes with Prophylactic Infusions Starting at
Least a Week Apart
6:24 p.m. March 28, 2014
- BusinessWire - BZX

Critical Alerts For DirecTV, Biogen Idec, Time Warner, Isis Pharmaceuticals, and DreamWorks Animation Released By InvestorsObserver
9:31 a.m. March 27, 2014
- PR Newswire - PRF

Pharmaceutical Executive to Unveil Brand of the Year Award Recipients at iPharma 2014: CBI's Marketing Innovation Summit
12:11 p.m. March 26, 2014
- PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

2027 Toy of the Year Finalists Energize Play Market

A Kaleidoscope of Innovation in Toys There's a familiar buzz in the air, folks. The 2027 Toy of the Year Awards finalists have been unveiled, and they're bringing a fresh wave of creativity to children's playrooms. These aren't just toys; they're miniature innovators ready to light up the market this holiday season. The reveal happened at the Chicago Toy & Game Fair and...

Paris Baguette Pioneers Drive-Thru in Oklahoma

Tapping The Unseen Potential In Bakery Cafes Every so often a business move comes along that makes you sit up and say, "Why the hell haven't they done this before?" Paris Baguette has finally cracked that code, rolling out its first-ever drive-thru in Moore, Oklahoma. Now, imagine yourself zipping through for a croissant without leaving the comfort of your car seat. Makes...

7th World Media Summit Spotlights Media's Future in Beijing

The Changing Landscape of Global Media An event of this magnitude doesn't just pop up every day like a stock ticker on Wall Street. This year's 7th World Media Summit in Beijing is where nearly 500 bigwigs from all corners of the media landscape are converging. It's not about trading stocks or hitting quarterly numbers—it's about shaping how stories get told in an era...

TCL's Display Future: AI Meets Screens at DTC 2026

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Historic Records Set at 2026 CNO Monumental Marathon

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Quantum Space Joins $185M NASA Lunar Transport Deal

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

J&J's New Study: Sjögren’s Solution Insight Sparks Debate

Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...

JOYEE N01 Kicks Off Global Launch with African Orders

A New Chapter for JOYEE N01 There's a moment in every company's life when it either steps boldly into the future or stumbles back into obscurity. For FAW Bestune, October 28, 2026, was one of those defining moments. On this day, they launched global mass production of the JOYEE N01 in Yancheng, China. And boy, did they pull out all the stops—you don't see this kind of...

Invasive Procedures Don't Extend Life in Stable Heart Disease

Challenging Longstanding Beliefs Today’s news from the heart research front might set a few cardiology heads spinning. We’ve got big-time findings out of the ISCHEMIA-EXTEND study, throwing more weight on the evidence pile that early invasive heart procedures for patients with stable coronary artery disease don’t actually extend your life. Managing care with a blend...

Johnson & Johnson Unveils Promising PsA Treatment Data

A Game-Changer in Psoriatic Arthritis Treatment? Johnson & Johnson just tossed a headline-grabbing bone into the world of psoriatic arthritis with their new ICOTYDE results. For anyone tangled in the chronic web of psoriatic arthritis, hearing about a potential new treatment like ICOTYDE comes with cautious hope. Between stiff joints and rashy skin, sufferers are often...